BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24922688)

  • 1. Histological growth pattern of and alpha-actinin-4 expression in thyroid cancer.
    Tanaka N; Yamashita T; Yamamoto S; Matsunobu T; Tsuda H; Honda K; Yamada T; Tamai S; Shiotani A
    Anticancer Res; 2014 Jun; 34(6):3157-63. PubMed ID: 24922688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
    Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
    Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
    Bhattacharyya N
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between the pathological characteristics and the prognosis of thyroid carcinoma].
    Liu FS
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):381-4. PubMed ID: 8174487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should an involved but functioning recurrent laryngeal nerve be shaved or resected in a locally advanced papillary thyroid carcinoma?
    Lang BH; Lo CY; Wong KP; Wan KY
    Ann Surg Oncol; 2013 Sep; 20(9):2951-7. PubMed ID: 23636513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thyroid cancers].
    Mogoş V; Zbranca E; Strat V; Diaconescu MR; Chifan M; Florea N; Costăchescu G; Găleşanu MR; Rusu V; Georgescu G
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):72-81. PubMed ID: 9524659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of p63 expression in thyroid neoplasm].
    Qian M; Wang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(19):888-90, 893. PubMed ID: 19160863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical therapy of differentiated thyroid gland carcinoma].
    Walgenbach S; Sternheim E; Bittinger F; Junginger T
    Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer.
    Nishida T; Nakao K; Hamaji M; Kamiike W; Kurozumi K; Matsuda H
    Ann Surg; 1997 Jul; 226(1):85-91. PubMed ID: 9242342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphadenectomy in thyroid gland carcinoma--staging and therapy].
    Pomorski L; Rybinski K
    Zentralbl Chir; 1996; 121(6):455-8. PubMed ID: 8767330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
    Tan H; Ye K; Wang Z; Tang H
    Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
    Grönberg M; Fjällskog ML; Jirström K; Janson ET
    Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.